Selective COX-2 inhibitor ameliorates osteoarthritis by repressing apoptosis of chondrocyte

Medical Science Monitor

Volumn 18, Issue 6, 2012, Pages

  Ou, Yunsheng ^a   Tan, Chao ^a   An, Hong ^a   Jiang, Dianming ^a   Quan, Zhengxue ^a   Tang, Ke ^a   Luo, Xiaoji ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Chondrocyte; Nonsteroidal anti inflammatory drugs; Osteoarthritis

Indexed keywords

CELECOXIB; COLLAGEN TYPE 2; CYCLOOXYGENASE 2 INHIBITOR; EOSIN; HEMATOXYLIN; IBUPROFEN; INDOMETACIN; SODIUM CHLORIDE;

ACHILLES TENDON; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; ELECTRON MICROSCOPE; EXCISION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; NICK END LABELING; NONHUMAN; OSTEOARTHRITIS; PROTEIN EXPRESSION; RAT; STAINING; SYMPTOM; TRANSMISSION ELECTRON MICROSCOPE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

EID: 84863551111     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882901     Document Type: Article

References (29)

1. Creamer P, Hochberg MC: Osteoarthritis. Lancet, 1997; 350: 503-9
2. Felson DT, Naimark A, Anderson J et al: The prevalence of knee osteo-arthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis & Rheumatism, 1987; 30(8): 914-18
3. Blanco FJ, Guitian R, Vazquez-Martul E et al: Osteoarthritis chondrocytes die by apoptosis: a possible pathway for osteoarthritis pathology. Arthritis & Rheumatism, 1987; 42(2): 914-18
4. Hashimoto S, Takahashi K, Amiel D et al: Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis & Rheumatism, 1998; 41(7): 1266-74
5. Yatsugi N, Tsukazaki T, Osaki M et al: Apoptosis of articular chondrocytes in rheumatoid arthritis and osteoarthritis: correlation of apoptosis with degree of cartilage destruction and expression of apoptosis-re-lated proteins of p53 and c-myc. J Orthop Sci, 2000; 5(2): 150-6.
6. Kirscha T, Swobodab B, Nah HD: Activation of annexin II and V expression, terminal differentiation, mineralization and apoptosis in human osteoarthritic cartilage. Arthritis & Rheumatism, 2000; 8(4): 294-302
7. Hamel MB,Toth M,Legedza A et al: Joint replacement surgery in elderly patients with severe osteoarthritis of the hip or knee: decision making, postoperative recovery, and clinical outcomes. Arch Intern Med, 2008; 168(13): 1430-40
8. Ding C: Do NSAIDs affect the progression of osteoarthritis? Inflammation, 2002; 26: 139-42
9. Olszewska-Słonina DM, Matewski D, Drewa G et al: Oxidative equilibrium in the prophylaxis of degenerative joint changes: an analysis of pre-and postoperative activity of antioxidant enzymes in patients with hip and knee osteoarthritis. Med Sci Monit, 2010; 16(5): CR238-45
10. Mastbergen SC, Marijnissen AC, Vianen ME et al: Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis. Rheumatology, 2006; 45(4): 405-13
11. Mastbergen SC, Bijlsma JW, Lafeber FP: Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study. Osteoarthritis Cartilage, 2005; 13(6): 519-26
12. Zweers MC, de Boer TN, van Roon J et al: Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis. Arthritis Res Ther, 2011; 13: 239-50
13. Goggs R, Carter SD, Schulze-Tanzil G et al: Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis. Vet J, 2003; 166 140-58
14. Gu Y, Dai KW, Qiu SJ et al: A morphological study of degenerative mechanism of articular cartilage induced by low stress. Chin J Orthop,1995; 15(9): 631-33
15. Xu SY, Pian RL, Chen X: The methodology of pharmacological experiment [M]. People's Medical Publishing House, Beijing, China, 2005; 406
16. Squives GR, OKouneff S, Ionescu M et al: The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis. Arthritis Rheum, 2003; 48(5): 1261-70
17. Lavigne P, Benderdour M, Lajeunesse D et al: Subchondral and trabec-ular bone metabolism regulation in canine experimental knee osteoarthritis. Osteoarthritis Cartilage, 2005; 13(4): 310-17
18. Hajjaji H, Marcelis A, Devogelaer JP et al: Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage. J Rheumatol, 2003; 30: 2444-51
19. Mastbergen SC, Bijlsma JW, Lafeber FP: Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a hu-man in vitro study. Osteoarthritis Cartilage, 2005; 13: 519-26
20. Mastbergen SC, Lafeber FP, Bijlsma JW: Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage. Rheumatology, 2002; 41: 801-8
21. de Boer TN, Huisman AM, Polak AA et al: The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment. Osteoarthritis Cartilage, 2009; 17: 482-88
22. Garnero P, Ayral X, Rousseau JC et al: Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum, 2002; 46(10): 2613-24
23. Nelson F, Dahlberg L, Laverty S et al: Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest, 1998; 102: 2115-25
24. Chen SW, Wei XC, Xiang C et al: Experimental study of collagen I, II and III in osteoarthritic articular cartilage. Journal of Shanxi Medical University, 2006; 37(3): 248-51
25. Thomas CM, Fuller CJ, Whittles CE et al: Chondrocyte death by apoptosis is associated with cartilage matrix degradation. Osteoarthritis Cartilage, 2007; 15(1): 27-34
26. Mistry D, Oue Y, Chambers MG et al: Chondrocyte death during murine osteoarthritis. Osteoarthritis Cartilage, 2004; 12(2): 131-41
27. Kusunoki N,Yamazaki R, Kawai S: Induction of Apoptosis in Rheumatoid Synovial Fibroblasts by Celecoxib, but Not by Other Selective Cyclooxygenase 2 Inhibitors. Arthritis Rheumatism, 2002; 12: 3159-67
28. Mastbergen SC, Lafeber FP, Bijlsma JW: Selective COX-2 inhibition prevents proinflammatory cytokine induced cartilage damage. Rheumatolgy, 2002; 41: 801-8
29. Lotz M, Hashimoto S, Kuhn K: Mechanisms of chondrocyte apoptosis. Osteoarthritis Cartilage, 1999; 7: 389-91